Search PubMed⌕ Search

Biomedical subjects

H Ohkuma

Publications and source records attributed to H Ohkuma.

140 records · Page 8Linked to original sources

BBM-928, a new antitumor antibiotic complex. III. Structure determination of BBM-928 A, B and C.

Structures of antitumor antibiotics BBM-928 A, B and C have been determined. They are cyclic decadepsipeptides containing 3-hydroxy-6-methoxyquinaldic acid as a chromophore. Two amino acids, not found in nature, L-beta-hydroxyl-N-methylvaline and trans-(3S,4S)-4-hydroxy-2,3,4,5-tetrahydropyridazine-3-carboxylic acid, were identified as structural constituents of the antibiotic. In gross structure, BBM-928 resembles the echinomycin group of antibiotics which are cyclic octadepsipeptides having a quinoxaline chromophore, but BBM-928 differs from the latter group by virtue of the lack of a sulfur-containing cross linkage.

Antibiotics, Antineoplastic↗

BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity.

A complex of the antitumor antibiotic BBM-928 was produced by an actinomycete strain No. G455-101. Four components, BBM-928 A, B, C and D, were isolated in crystalline form and characterized. They were shown to be cyclic depsipeptide antibiotics containing a quinoline nucleus as the chromophore. BBM-928 A is a monoacetyl derivative of BBM-928 B and a diacetyl derivative of BBM-928 C. BBM-928 components exhibit antimicrobial activity against Gram-positive and acid-fast bacteria. BBM-928 A is highly active in mice against various experimental tumors including leukemia P388, leukemia L1210, melanoma B16, LEWIS lung carcinoma and sarcoma 180. BBM-928 B is less active than BBM-928 A, and BBM-928 C has no antitumor activity.

Animals↗

Detection of luciferase having two kinds of luminescent colour based on optical filter procedure: application to an enzyme immunoassay.

This paper reports on our study using several optical filters known to be efficient in separating compounds having various levels of maximum luminescence, to separate information from three kinds of Luciola lateralis luciferase with a maximum luminescence of 559 nm, 604 nm and 607 nm. Simultaneous luminescence of Luciola lateralis luciferase was determined by measuring the luminescence through a band pass filter or sharp cut filter (BPB50, 53, 58, No.58, SC58, 60, 62, 64). It was possible to determine luciferase with a maximum luminescence lambda(max) of 559 nm (yellow-green) utilizing the band pass filter (BPB 50), described here. Meanwhile, luciferase with a lambda(max) of 607 nm (red) could be determined by calculations based on the bioluminescent intensity through the band pass filter and sharp cut filter (SC58). In addition, we also applied a simultaneous bioluminescent enzyme immunoassay of pepsinogen I (PGI) and pepsinogen II (PGII) in which two kinds of biotinylated luciferase (Luciola lateralis) labelled as an enzyme producing yellow-green light (lambda(max) = 559 nm) and red light (lambda(max) = 607 nm) were used. In the proposed method, PGI and PGII in serum were simultaneously captured in a sandwich-type immune reaction between anti-PGI and anti-PGII monoclonal antibody-coated magnetic particles, and streptavidin-biotinylated luciferase biotinylated anti-PGI and anti-PGII monoclonal antibodies triplexes, respectively. The result was a calibration range for PGI of 2-200 ng/mL, and for PGII of 1-100 ng/mL. In conclusion, the correlation of PG values in serum between the proposed method (simultaneous assay) and an individual specific bioluminescent immunoassay (specific assay) were satisfactory.

Animals↗

Comparison of indocyanine green and fluorescein angiography of choroidal neovascularization.

We compared indocyanine green (ICG) and fluorescein angiography for evaluation of choroidal neovascularization (CNV). Cast preparations of CNV induced in monkey eyes by laser photocoagulation were correlated with ICG and fluorescein angiographies of the same CNV formations. Fluorescein angiography was more effective, in general, than ICG angiography in detecting CNV; however, CNVs with subretinal hemorrhage (2 of 35 sites) were visible only with ICG angiography. In early phase ICG angiography, CNV formations that casts showed to be dense or composed of thick vessels were seen, but less dense areas were not visible. Lesions that ICG angiography revealed as leaking were not differentiated morphologically from non-leaking areas by the CNV casts. This study confirms that only ICG angiography can identify CNV hidden by subretinal hemorrhage, although fluorescein angiography is otherwise superior. Indocyanine green angiography is indicated as a valuable complement to fluorescein angiography for evaluation of CNV.

Animals↗